All Articles

Streamex has successfully restructured its debt to chase the booming RWA market, but its latest board reshuffle raises serious NASDAQ governance questions.

Pliant Therapeutics taps veteran oncologist Dr. David Raben as CMO to steer its targeted ICI-refractory cancer program toward crucial 2027 clinical milestones.

By offloading its capital-heavy rental unit to Rotech, Inogen is rewriting its business model to focus on high-margin respiratory innovation and scale.

As Kinsale Capital prepares to release its Q3 2026 earnings, the spotlight is on how its proprietary tech will navigate rising storms and shifting E&S markets.

Targeted protein degradation is breaking out of oncology. Monte Rosa’s latest Phase 1 readout tests if molecular glues can solve residual heart disease risk.

Maybank and Synthesys are moving tokenised real-world assets beyond the US Dollar, unlocking new on-chain cash management tools for global treasuries.

Atlantic Digestive Specialists waited half a year to warn patients of a massive data breach. What this means for the future of medical privacy.

Casio unveils a 20-piece, $70,000 sapphire crystal G-SHOCK, transforming a utilitarian tool watch into a masterclass of ultra-luxury horological engineering.

Financial Software Solutions brings AI to bankruptcy administration, automating tedious document review while raising new questions about trustee liability.

Quorum Innovations has published early human data on Qi601, a postbiotic designed to trap microplastics in the gut before they enter human cells.

By integrating Cash App Pay, FastSpring is helping software sellers tap into mobile-first demographics and reduce checkout friction for recurring subscriptions.

Veridian Credit Union leverages its cooperative model to secure the No. 1 national ranking in Callahan & Associates' Return of the Member Index for Q2 2026.

Alexis Miestowski and Marissa Wenzler just became the Grass League's first female General Managers, merging digital influence with franchise leadership.

As Swiss regulators impose punishing post-Credit Suisse capital buffers, a major shareholder is demanding UBS relocate to preserve $36 billion in market value.

GOA Therapeutics is combining venture backing and institutional placements with retail crowdfunding as part of a $300 million strategy to fund its alcohol poisoning antidote candidate.

A new report reveals that despite rising high school graduation rates, California's Latinx students face systemic barriers to college readiness and degrees.

A new interdisciplinary hub at USC reveals how global corporate titans are leveraging strategic philanthropy to fuel the American innovation economy.

Behind SoftBank’s $3.1B acquisition of DigitalBridge lies a massive AI infrastructure play and a quiet revolution in corporate legal strategy.

As retail and hospitality jobs dry up and AI threatens white-collar roles, Gen Z is shattering the 'work-shy' myth by flocking to the construction industry.

Luke DeLaVergne joins Omni Family of Services as COO, bridging the gap between clinical empathy and the rigorous data demands of multi-state expansion.